Shell Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $276K | Sell |
490
-9,206
| -95% | -$5.21M | 0.03% | 420 |
|
|
2025
Q2 | $5.09M | Sell |
9,696
-120
| -1% | -$67K | 0.18% | 116 |
|
|
2025
Q1 | $6.23M | Sell |
9,816
-1,515
| -13% | -$1.04M | 0.3% | 60 |
|
|
2024
Q4 | $8.07M | Sell |
11,331
-230
| -2% | -$193K | 0.35% | 47 |
|
|
2024
Q3 | $12.2M | Buy |
+11,561
| New | +$12.9M | 0.53% | 31 |
|
|
2024
Q1 | $13.5M | Sell |
12,816
-1,365
| -10% | -$1.3M | 0.61% | 21 |
|
|
2023
Q4 | $12.5M | Sell |
14,181
-3,448
| -20% | -$2.84M | 0.58% | 26 |
|
|
2023
Q3 | $14.5M | Sell |
17,629
-1,250
| -7% | -$982K | 0.6% | 21 |
|
|
2023
Q2 | $13.6M | Sell |
18,879
-7,603
| -29% | -$5.86M | 0.54% | 27 |
|
|
2023
Q1 | $21.8M | Buy |
26,482
+230
| +0.9% | +$173K | 0.9% | 14 |
|
|
2022
Q4 | $18.9M | Sell |
26,252
-4,228
| -14% | -$3.12M | 0.83% | 17 |
|
|
2022
Q3 | $21M | Sell |
30,480
-1,732
| -5% | -$1.09M | 0.82% | 16 |
|
|
2022
Q2 | $19M | Sell |
32,212
-8,058
| -20% | -$5.24M | 0.56% | 30 |
|
|
2022
Q1 | $28.1M | Buy |
40,270
+1,367
| +4% | +$865K | 0.66% | 21 |
|
|
2021
Q4 | $24.6M | Buy |
38,903
+7,224
| +23% | +$4.44M | 0.5% | 28 |
|
|
2021
Q3 | $19.2M | Sell |
31,679
-7,662
| -19% | -$4.76M | 0.43% | 39 |
|
|
2021
Q2 | $22M | Buy |
39,341
+19,699
| +100% | +$9.98M | 0.43% | 37 |
|
|
2021
Q1 | $9.29M | Sell |
19,642
-11,076
| -36% | -$5.39M | 0.19% | 123 |
|
|
2020
Q4 | $14.8M | Buy |
30,718
+3,583
| +13% | +$1.93M | 0.31% | 63 |
|
|
2020
Q3 | $15.2M | Sell |
27,135
-1,292
| -5% | -$783K | 0.35% | 54 |
|
|
2020
Q2 | $17.7M | Buy |
28,427
+12,194
| +75% | +$6.92M | 0.44% | 46 |
|
|
2020
Q1 | $7.93M | Sell |
16,233
-2,256
| -12% | -$931K | 0.22% | 115 |
|
|
2019
Q4 | $6.94M | Buy |
18,489
+542
| +3% | +$182K | 0.15% | 180 |
|
|
2019
Q3 | $4.98M | Sell |
17,947
-400
| -2% | -$118K | 0.11% | 210 |
|
|
2019
Q2 | $5.74M | Sell |
18,347
-559
| -3% | -$186K | 0.13% | 199 |
|
|
2019
Q1 | $7.76M | Hold |
18,906
| – | – | 0.17% | 156 |
|
|
2018
Q4 | $7.06M | Buy |
18,906
+6,950
| +58% | +$2.54M | 0.18% | 153 |
|
|
2018
Q3 | $4.83M | Buy |
11,956
+1,764
| +17% | +$671K | 0.1% | 243 |
|
|
2018
Q2 | $3.52M | Buy |
10,192
+204
| +2% | +$63.8K | 0.07% | 295 |
|
|
2018
Q1 | $3.44M | Sell |
9,988
-126
| -1% | -$43.8K | 0.07% | 292 |
|
|
2017
Q4 | $3.8M | Sell |
10,114
-1,813
| -15% | -$734K | 0.08% | 270 |
|
|
2017
Q3 | $5.33M | Sell |
11,927
-509
| -4% | -$242K | 0.12% | 211 |
|
|
2017
Q2 | $6.11M | Sell |
12,436
-2,566
| -17% | -$1.12M | 0.13% | 202 |
|
|
2017
Q1 | $5.81M | Sell |
15,002
-172
| -1% | -$63.8K | 0.13% | 197 |
|
|
2016
Q4 | $5.57M | Sell |
15,174
-656
| -4% | -$249K | 0.13% | 193 |
|
|
2016
Q3 | $6.36M | Sell |
15,830
-267
| -2% | -$107K | 0.13% | 197 |
|
|
2016
Q2 | $5.62M | Buy |
16,097
+3,971
| +33% | +$1.53M | 0.13% | 183 |
|
|
2016
Q1 | $4.37M | Buy |
12,126
+2,485
| +26% | +$1.02M | 0.1% | 206 |
|
|
2015
Q4 | $5.23M | Sell |
9,641
-5,794
| -38% | -$3.14M | 0.12% | 163 |
|
|
2015
Q3 | $5.57M | Buy |
15,435
+2,151
| +16% | +$1.16M | 0.09% | 202 |
|
|
2015
Q2 | $6.78M | Sell |
13,284
-1,388
| -9% | -$677K | 0.14% | 167 |
|
|
2015
Q1 | $6.62M | Sell |
14,672
-3,343
| -19% | -$1.42M | 0.12% | 187 |
|
|
2014
Q4 | $7.39M | Buy |
18,015
+2,580
| +17% | +$1.01M | 0.12% | 194 |
|
|
2014
Q3 | $5.57M | Buy |
15,435
+262
| +2% | +$87.8K | 0.09% | 209 |
|
|
2014
Q2 | $4.29M | Sell |
15,173
-753
| -5% | -$223K | 0.07% | 266 |
|
|
2014
Q1 | $4.78M | Sell |
15,926
-467
| -3% | -$144K | 0.08% | 240 |
|
|
2013
Q4 | $4.51M | Sell |
16,393
-7,411
| -31% | -$2.13M | 0.08% | 237 |
|
|
2013
Q3 | $7.45M | Sell |
23,804
-874
| -4% | -$230K | 0.14% | 167 |
|
|
2013
Q2 | $5.55M | Buy |
+24,678
| New | +$5.75M | 0.11% | 214 |
|
Other funds holding REGN
Shell Asset Management's REGN Position: Q3 2025 in Review
Shell Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 95% in Q3 2025, selling an estimated $5.21M and leaving 490 shares worth $276K. The position accounts for 0.03% of the portfolio, ranked #420.
Shell Asset Management first reported a position in REGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $28.1M in Q1 2022. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.
- Shell Asset Management held 490 shares of Regeneron Pharmaceuticals worth $276K as of Q3 2025.
- Shell Asset Management sold 9,206 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $5.21M.
- Regeneron Pharmaceuticals made up 0.03% of Shell Asset Management's portfolio in Q3 2025, its #420 holding.
- Shell Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- Shell Asset Management's Regeneron Pharmaceuticals position peaked at $28.1M in Q1 2022.
- 1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.